- Home
- Products
Rolvedon (Eflapegrastim-xnst)
Rolvedon (Eflapegrastim-xnst)
- Medicine Name: Rolvedon
- Generic Name: Eflapegrastim-xnst
- Dosage Form & Strength: Injection – 13.2 mg/0.6 mL solution
- Manufactured By: Spectrum Pharmaceuticals, Inc.
Rolvedon (eflapegrastim-xnst) is a long-acting granulocyte colony-stimulating factor (G-CSF) used to lower the risk of infections caused by febrile neutropenia in adults receiving myelosuppressive chemotherapy for non-myeloid cancers.
Limitations of Use: Rolvedon is not approved for mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.
Recommended Dosage:
- 13.2 mg via subcutaneous injection once per chemotherapy cycle
- Administer approximately 24 hours after cytotoxic chemotherapy
- Avoid use within 14 days before or 24 hours after chemotherapy
Splenic Rupture: May occur after treatment. Monitor patients reporting left upper abdominal or shoulder pain.
ARDS (Acute Respiratory Distress Syndrome): Assess respiratory symptoms promptly. Discontinue if ARDS develops.
Severe Allergic Reactions: Includes anaphylaxis. Do not administer to patients with a known allergy to eflapegrastim, pegfilgrastim, or filgrastim. Permanently discontinue in case of hypersensitivity.
Sickle Cell Crisis: Patients with sickle cell disorders should be closely monitored. Discontinue if a crisis occurs.
Leukocytosis: White blood cell count may exceed 100 x 10^9/L. Monitor CBC and discontinue if levels are excessive.
Thrombocytopenia: Platelet counts should be monitored throughout therapy.
Secondary Malignancies: Cases of AML and MDS have been reported in patients undergoing chemo/radiotherapy for lung or breast cancer. Regular monitoring is advised.
Required Documents for Import:
- Valid prescription from a licensed medical practitioner
- Patient’s diagnostic reports
- Government-issued identity proof
Order Confirmation:
- Confirmation occurs upon receipt of the prescription and import permit (if applicable)
Availability in India: Rolvedon is made available in India through Global Rare Meds under the Named Patient Supply (NPS) program. We assist patients, doctors, and hospitals in sourcing Rolvedon legally and ethically from certified suppliers in the USA, Europe, Canada, and Australia.
Available in cities including Mumbai, Delhi, Pune, Hyderabad, Chennai, Bangalore, Kolkata, Ahmedabad, Jaipur, Lucknow, Chandigarh, Ludhiana, and more.
To enquire about price or delivery:
- Phone/WhatsApp: +91-99675 15602
- Email: info@globalraremeds.com
Global Rare Meds sources Rolvedon from reputed international suppliers and delivers it directly to patients across India. All prescriptions are validated by certified pharmacists, and shipments are dispatched from our fulfillment center in Ambernath, Thane District.
We prioritize safe packaging, compliance with import regulations, and timely dispatch.
What is the Generic Name for Rolvedon®?
Eflapegrastim-xnst
Who manufactures Rolvedon®?
Spectrum Pharmaceuticals, Inc.
Is Rolvedon® FDA approved?
Yes. FDA approval was granted on September 9, 2022.
Where can I get Rolvedon® in India?
Rolvedon is available through Global Rare Meds. A valid doctor’s prescription is required for procurement.
What form is Rolvedon® supplied in?
Injection: 13.2 mg/0.6 mL solution in a prefilled syringe for subcutaneous use.
What are the common side effects?
Headache, fatigue, bone pain, diarrhea, pyrexia, nausea, anemia, rash, myalgia, and back or joint pain.
How much does Rolvedon® cost in India?
Prices may vary. Contact Global Rare Meds at +91-99675 15602 or email info@globalraremeds.com for updated pricing.
Storage Conditions:
Refrigerate at 2–8°C. Store in original packaging away from light. Do not freeze or shake. Discard if frozen.
Can Rolvedon® be safely purchased online in India?
Yes. It can be safely procured online through Global Rare Meds via authorized and legally compliant channels.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
